Drug Type Synthetic peptide |
Synonyms |
Target |
Mechanism C5AR1 antagonists(C5a anaphylatoxin chemotactic receptor antagonists), C5AR2 antagonists(complement component 5a receptor 2 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Peritonitis | Preclinical | DE | 01 Oct 2006 |